A Phase 1, Single-Dose, Randomized, Group Sequential Cross-Over Study Evaluating the Bioavailability and Food Effect of Three Formulations of Veliparib on Pharmacokinetics in Subjects With Solid Tumors.
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Veliparib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
Most Recent Events
- 04 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
- 19 Sep 2010 New trial record